Clinical relevance of Minimal residual Disease assessment by NGS in Multiple Myeloma

被引：0
|
作者：
Martinez-Lopez, Joaquin [1 ]
Wong, Sandy [2 ]
Shah, Nina [2 ]
Bahri, Natasha [3 ]
Zhou, Kali [3 ]
Martin, Thomas [2 ]
Wolf, Jeffrey [2 ]
机构：
[1] Hosp 12 Octubre, Madrid, Spain
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] UCSF, San Francisco, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Minimal residual disease; Next Generation Sequencing;
D O I：
10.1016/j.clml.2019.09.300
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP-215
引用
收藏
页码：E179 / E180
页数：2
相关论文
共 50 条
  • [1] Clinical relevance and prognostic value of minimal residual disease in multiple myeloma.
    Terragna, C
    Martinelli, G
    Rossi, M
    Bonifazi, F
    Soverini, S
    Amabile, M
    Giannini, B
    Ottaviani, E
    Buonamici, S
    Zamagni, E
    Cellini, C
    Tosi, P
    Tura, S
    Cavo, M
    Baccarani, M
    BLOOD, 2002, 100 (11) : 599A - 599A
  • [2] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    HAEMATOLOGICA, 2024, 109 (07) : 2049 - 2059
  • [3] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2049 - 2059
  • [4] RESPONSE ASSESSMENT IN MULTIPLE MYELOMA: CLINICAL SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE MONITORING
    Paiva, Bruno
    Vidriales, Maria-Belen
    Montalban, Maria-Angeles
    Blade, Joan
    Lahuerta, Juan-Jose
    Orfao, Alberto
    San Miguel, Jesus F.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 390 - 390
  • [5] Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
    Nishihori, Taiga
    Song, Jinming
    Shain, Kenneth H.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (02) : 118 - 126
  • [6] Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
    Taiga Nishihori
    Jinming Song
    Kenneth H. Shain
    Current Hematologic Malignancy Reports, 2016, 11 : 118 - 126
  • [7] Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
    Charalampous, Charalampos
    Kourelis, Taxiarchis
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [8] MINIMAL RESIDUAL DISEASE IN THE CLINICAL PRACTICE OF MULTIPLE MYELOMA PATIENTS
    Cedena, M. T.
    Puig, N.
    Paiva, B.
    Perez, A.
    De Arriba, F.
    Cuellar, C.
    Blanchard, M. J.
    Martinez-Chamorro, C.
    Casanova, M.
    Sirvent, M.
    Rodriguez-Otero, P.
    Martinez-Lopez, J.
    Mateos, M., V
    San Miguel, J. F.
    Lahuerta, J. J.
    HAEMATOLOGICA, 2019, 104 : 15 - 15
  • [9] Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques
    Noa Biran
    Scott Ely
    Ajai Chari
    Current Hematologic Malignancy Reports, 2014, 9 : 368 - 378
  • [10] Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques
    Biran, Noa
    Ely, Scott
    Chari, Ajai
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (04) : 368 - 378
12345